Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
Abstract Background Ovarian cancer (OC) is the deadliest gynecological cancer. The absence of biomarkers in early detection and chemotherapy resistance is a principal cause of treatment failure in OC. Methods In this study, next generation sequencing (NGS) was used to sequence the mRNA of 44 OC pati...
Main Authors: | Hui Zheng, Meiqin Zhang, Shuang Ma, Wenting Yang, Suhong Xie, Yanchun Wang, Yixuan Liu, Jinyan Kai, Qian Ma, Renquan Lu, Lin Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.3122 |
Similar Items
-
Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy
by: Yen-Fu Chen, et al.
Published: (2024-01-01) -
TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
by: Yixuan Liu, et al.
Published: (2021-10-01) -
Three-step chemotherapy treatment for platinum-sensitive recurrent ovarian cancer: a review of 20 cases
by: CAI Shumo, TANG Jie, HUANG Xiao, HUANG Xiaowei, LIU Suping, KE Guihao, ZHENG Zhong, CHENG Xi, TANG Meiqin
Published: (2021-04-01) -
MUS81 Participates in the Progression of Serous Ovarian Cancer Associated With Dysfunctional DNA Repair System
by: Renquan Lu, et al.
Published: (2019-11-01) -
Chemotherapy Associated Ovarian Failure
by: Davide Mauri, et al.
Published: (2020-12-01)